Doctors fear growing signs of drug resistance
Physicians warn antibiotic resistant bacteria are spreading worldwide, reducing treatment options. Experts cite rising costs, multi resistant strains, and misuse in humans and animal feed as key factors. Studies note higher illness burden and ongoing search for new drugs amid global health risk.
MENTIONED IN THIS ARTICLE
Ann Arbor
United States
Schaberg
University of Michigan
Ann Arbor Veterans Administration
Stuart B. Levy
Tufts Diversity School of Medicine
Thomas ’Brien
Hard Medical School
National Institutes of ‘sHealth
inAnnapolis
Philadelphia
Alexander Tomasz
Rockefeller University
Dallas
George H. McCracken, Jr
University of Texas’ Southwestern‘Medical Center
Tomasz
Barbara EB. Murray
University of Texas Medical School
Houston
Richard Novick
Public Health Research Institute
New York City
Central America
Rai Sey
Developing Countries
World Health Organization
Centers For Disease Control
Los Angeles
East
Africa
O'Brien
Aspirin and Alcohol Mix Raises Drunkness Risk
A study reported in JAMA found aspirin plus alcohol increases blood alcohol levels by about 34 percent after a standard breakfast with aspirin. Researchers caution full stomachs and morning dosing for aspirin users who plan to drink, noting women may be more susceptible.
MENTIONED IN THIS ARTICLE
Chicago
Journal of the American Medical Association
Charles S. Lieber
Alcohol Research Center
Bronx Veterans Affairs Medical Center
New York
Lieber
Ernest P. Noble
University of California In
Los Angeles
Noble
National Institute On Alcohol Abuse and Alcoholism
Panel's delay may have cost lives
A panel of 16 AIDS specialists concluded steroids can cut in half death rates from pneumocystis carinii pneumonia, the leading AIDS killer. The institute delayed notifying doctors by five months, mailing letters only on Oct. 10 to 2,500 practitioners. The finding, made in May, was publicly revealed later by AIDS Treatment News amid doctor and advocate outrage.
MENTIONED IN THIS ARTICLE
United States
National Institute of Allergy and Infectious Diseases
Institute
Fujisawa Pharmaceuticals Co
Deerfield
Aids Treatment News
Mathilde Krim
American Foundation For Aids Werea
Newark
Radical cancer gene therapy cleared by FDA approval
The FDA approved a radical experimental cancer treatment after a rigorous review. Genetically engineered blood cells carrying tumor necrosis factor will be used to target and destroy tumors, starting tests on three patients in four to six weeks. Metastatic melanoma, resistant to chemo and radiation, is the initial focus.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
Steven A. Rosenberg
National Cancer Institute
Bethesda
Also Mentioned on This Page
Glenbrook Laboratories
Myerstown
Associated Press
Lake Onondaga
Flo
New York Times News Service
Rosenburg